RXST
RxSight, Inc.NASDAQHealthcare$6.64+5.72%ClosedMarket Cap: $274.0M
As of 2026-04-06
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-09 | Stifel | maintain | Hold | Hold |
| 2026-02-26 | Piper Sandler | maintain | Neutral | Neutral |
| 2026-02-26 | UBS | maintain | Neutral | Neutral |
| 2026-02-26 | Needham | maintain | Buy | Buy |
| 2026-01-20 | Piper Sandler | maintain | Neutral | Neutral |
| 2025-12-02 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| 2025-11-06 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| 2025-11-06 | JP Morgan | maintain | Underweight | Underweight |
| 2025-11-06 | Needham | maintain | Buy | Buy |
| 2025-08-08 | UBS | maintain | Neutral | Neutral |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Wed Dec 31 | $-1.05 | $131.6M | 5 |
| Thu Dec 31 | $-1.30 | $131.0M | 4 |
| Fri Dec 31 | $-1.18 | $143.9M | 5 |
| Sun Dec 31 | $-1.18 | $149.0M | 2 |